BONIVA is a prescription medication that belongs to the class of bisphosphonates. It is primarily used in the treatment and prevention of osteoporosis in postmenopausal women, helping to reduce the risk of fractures. BONIVA works by inhibiting bone resorption, leading to an increase in bone mineral density and overall bone strength.
USD $0.00
IndiaBONIVA (Ibandronate) is a prescription medication used to treat and prevent osteoporosis in postmenopausal women. It belongs to a class of drugs known as bisphosphonates, which work by inhibiting bone resorption, ultimately increasing bone density and reducing the risk of fractures.
BONIVA works by binding to the bone tissue and inhibiting the activity of osteoclasts, the cells responsible for bone breakdown. This action helps to maintain bone strength and integrity, making it less likely for bones to fracture.
BONIVA is typically prescribed for postmenopausal women who are at risk for osteoporosis. Your healthcare provider will determine if BONIVA is appropriate for you based on your medical history and bone density measurements.
BONIVA is available in both oral tablet and intravenous (IV) formulation. The oral tablet is usually taken once a month, while the IV form may be administered once every three months. It is important to follow your doctor's instructions regarding dosage and administration.
Common side effects of BONIVA may include gastrointestinal issues such as nausea, diarrhea, and abdominal pain. More serious side effects can occur, such as jaw problems (osteonecrosis) and atypical femur fractures. Always consult your healthcare provider if you experience any unusual symptoms.
Before starting BONIVA, inform your healthcare provider about any medical conditions you have, particularly kidney problems, esophageal issues, or if you are pregnant or breastfeeding. Additionally, discuss any other medications or supplements you are taking to avoid potential interactions.
BONIVA should not be used by individuals with known hypersensitivity to ibandronate or any component of the formulation. It is also contraindicated in patients with certain esophageal disorders or those who cannot sit or stand upright for at least 60 minutes after taking the medication.
It is important to inform your healthcare provider about all medications you are currently taking, as some drugs may interact with BONIVA. This includes antacids, calcium supplements, and other bisphosphonates.
BONIVA is an effective treatment option for managing osteoporosis in postmenopausal women. Always consult with your healthcare provider for personalized advice and to ensure it is the right medication for your needs.
